PainReform Ltd.

PainReform Ltd. is a clinical-stage specialty pharmaceutical company primarily focused on reformulating established pain therapeutics to enhance their efficacy and safety. The company's objective is to address unmet medical needs in the pain management industry by improving the pharmacokinetics of existing drugs. PainReform Ltd.'s efforts are concentrated on developing new drug delivery platforms that extend the duration of drug effects, potentially reducing the dependency on opioids for pain relief. Through its innovative approach, PainReform aims to target conditions such as postoperative pain, which affects a wide range of patients undergoing surgical procedures. Headquartered in Israel, the company leverages research and development to position itself within the broader pharmaceutical and healthcare sectors. PainReform Ltd. plays a significant role in the medical community's ongoing efforts to find safer, more effective pain management solutions, contributing to advancements in patient care and satisfaction.